RGS10 and ovarian carcinoma: Our previous work suggests that suppression of RGS10 expression contributes to the development of chemoresistance during ovarian cancer progression through amplification of endogenous survival signaling pathways [2], [15], and results presented here suggest that HDAC1 contributes to the loss of RGS10 expression in chemoresistant ovarian cancer cells.